Bavachin Attenuates Cognitive Impairment in Scopolamine‐Induced Amnesia: Behavioral, Biochemical and Molecular Insights
Drug Development Research · 2026-11 · 87 (7)
DOI: 10.1002/ddr.70394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 09.10.2026. Verfasst von Md Shadin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh. Hauptthemen laut MEDLINE: Amnesia, Cholinesterase Inhibitors, Cognitive Dysfunction, Flavonoids. Die Arbeit nennt 38 Literaturangaben. Gefördert von: This work was supported by the Deanship of Research and Graduate Studies at King Khalid University through a Small Research Project.
Abstract (Originalsprache)
Cholinergic dysfunction is a key feature of cognitive impairment, and currently available acetylcholinesterase (AChE) inhibitors provide limited symptomatic benefit and are often associated with adverse effects. This study evaluated the cognitive‐protective effects of bavachin (BVC), a prenylated flavonoid from Psoralea corylifolia, and its interaction with Donepezil (DNP) in a scopolamine (SCP)‐induced amnesia model. Male Swiss albino mice were pretreated with BVC (10–40 mg/kg), DNP (2.5 mg/kg), or their combination for 7 days prior to SCP challenge, followed by assessment using multiple behavioral paradigms, including novel object recognition, elevated plus maze, passive avoidance, Y‐maze, and Morris water maze. BVC attenuated SCP‐induced memory deficits in a dose‐dependent manner, with the 40 mg/kg dose producing performance statistically comparable to, though not formally demonstrated to be equivalent to, the normal control across tests. Bliss independence analysis of behavioral endpoints indicated predominantly additive interactions, with occasional greater‐than‐additive trends. Biochemical evaluation demonstrated that BVC inhibits AChE in vitro (IC 50 = 27.7 µM) and attenuates SCP‐induced elevations of AChE activity ex vivo in the frontal cortex and hippocampus. Combination treatment showed a greater‐than‐additive interaction in the frontal cortex (ΔBliss = 0.054) and an approximately additive effect in the hippocampus (ΔBliss = 0.013). Molecular docking and molecular dynamics simulations further suggested stable binding of BVC within the active sites of AChE and butyrylcholinesterase (BChE). Collectively, these findings indicate that BVC attenuates cognitive deficits, at least in part, through cholinesterase inhibition, and exhibits additive effects with DNP, supporting its potential as an adjunctive candidate for cognitive disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh.
- Bioinformatics and Drug Innovation Laboratory, BioLuster Research Center Ltd., Gopalganj, Bangladesh.
- Animal Science and Veterinary Medicine, Gopalganj Science and Technology University, Gopalganj, Bangladesh.
- Department of Emergency Medical Services, College of Applied Medical Sciences, Khamis Mushait Campus, King Khalid University (KKU), Abha, Saudi Arabia.
- Department of Maternal and Child Health Nursing, College of Nursing, Khamis Mushait Campus, King Khalid University (KKU), Abha, Saudi Arabia.
- Department of Biochemistry and Molecular Biology, Gopalganj Science and Technology University, Gopalganj, Bangladesh.
ORCID-Profile: Md Shadin, Talat Ali, Farha Farahim, Mohammed Alfaifi, Faisal H Altemani, Abdullah H Altemani, Faisal Alsenani, Muhammad Torequl Islam
Förderung
- This work was supported by the Deanship of Research and Graduate Studies at King Khalid University through a Small Research Project
Zitieren
APA
Shadin, M., Barua, M. B., Ali, T., Farahim, F., Ripon, M., Linkon, M. H., Shakil, M., Alfaifi, M., Altemani, F. H., Altemani, A. H., Alsenani, F., & Islam, M. T. (2026). Bavachin Attenuates Cognitive Impairment in Scopolamine‐Induced Amnesia: Behavioral, Biochemical and Molecular Insights. Drug Development Research, 87(7). https://doi.org/10.1002/ddr.70394
Vancouver
Shadin M, Barua MB, Ali T, Farahim F, Ripon M, Linkon MH, et al. Bavachin Attenuates Cognitive Impairment in Scopolamine‐Induced Amnesia: Behavioral, Biochemical and Molecular Insights. Drug Development Research. 2026;87(7). doi:10.1002/ddr.70394
BibTeX
@article{Shadin2026,
author = {Shadin, Md and Barua, Monisha Brati and Ali, Talat and Farahim, Farha and Ripon, Md and Linkon, Mehedi Hasan and Shakil, Md and Alfaifi, Mohammed and Altemani, Faisal H and Altemani, Abdullah H and Alsenani, Faisal and Islam, Muhammad Torequl},
title = {Bavachin Attenuates Cognitive Impairment in Scopolamine‐Induced Amnesia: Behavioral, Biochemical and Molecular Insights},
journal = {Drug Development Research},
year = {2026},
volume = {87},
number = {7},
doi = {10.1002/ddr.70394}
}
EUVIMED